| NTRA |
Natera, Inc. |
0 |
4.05% |
|
|
|
|
|
N/A |
0.00% |
53.42% |
16.92% |
|---|
| TWST |
Twist Bioscience Corporation |
0 |
3.85% |
|
|
|
|
|
N/A |
0.00% |
66.71% |
37.00% |
|---|
| VCEL |
Vericel Corporation |
0 |
2.79% |
|
|
|
|
|
N/A |
0.00% |
58.27% |
74.40% |
|---|
| NZYMB.CO |
Novozymes A/S |
|
2.72% |
|
|
|
|
|
|
|
|
|
|---|
| BPMC |
Blueprint Medicines Corporation |
0 |
2.51% |
|
|
|
|
|
N/A |
0.00% |
66.68% |
-1.50% |
|---|
| VCYT |
Veracyte, Inc. |
0 |
2.51% |
|
|
|
|
|
N/A |
0.00% |
62.23% |
31.55% |
|---|
| LLY |
Eli Lilly and Company |
0 |
2.35% |
|
|
|
|
|
N/A |
0.00% |
40.95% |
42.16% |
|---|
| GERN |
Geron Corporation |
0 |
2.08% |
|
|
|
|
|
N/A |
0.00% |
92.88% |
14.58% |
|---|
| BBIO |
BridgeBio Pharma, Inc. |
0 |
2.02% |
|
|
|
|
|
N/A |
0.00% |
60.00% |
3.74% |
|---|
| AGIO |
Agios Pharmaceuticals, Inc. |
0 |
1.91% |
|
|
|
|
|
N/A |
0.00% |
67.83% |
40.49% |
|---|
| UTHR |
United Therapeutics Corporation |
0 |
1.84% |
|
|
|
|
|
N/A |
0.00% |
35.09% |
32.21% |
|---|
| IOVA |
Iovance Biotherapeutics, Inc. |
0 |
1.64% |
|
|
|
|
|
N/A |
0.00% |
764.53% |
60.34% |
|---|
| SRPT |
Sarepta Therapeutics, Inc. |
0 |
1.60% |
|
|
|
|
|
N/A |
0.00% |
82.04% |
56.49% |
|---|
| ALNY |
Alnylam Pharmaceuticals, Inc. |
0 |
1.53% |
|
|
|
|
|
N/A |
0.00% |
41.52% |
10.53% |
|---|
| NEO |
NeoGenomics, Inc. |
0 |
1.48% |
|
|
|
|
|
N/A |
0.00% |
47.40% |
43.69% |
|---|
| VRTX |
Vertex Pharmaceuticals Incorporated |
0 |
1.45% |
|
|
|
|
|
N/A |
0.00% |
29.42% |
23.44% |
|---|
| GILD |
Gilead Sciences, Inc. |
0 |
1.44% |
|
|
|
|
|
N/A |
0.00% |
45.18% |
73.01% |
|---|
| RARE |
Ultragenyx Pharmaceutical Inc. |
0 |
1.41% |
|
|
|
|
|
N/A |
0.00% |
71.90% |
96.83% |
|---|
| DHR |
Danaher Corporation |
0 |
1.40% |
|
|
|
|
|
N/A |
0.00% |
30.02% |
26.92% |
|---|
| BEAM |
Beam Therapeutics Inc. |
0 |
1.39% |
|
|
|
|
|
N/A |
0.00% |
63.92% |
40.25% |
|---|
| DD |
DuPont de Nemours, Inc. |
0 |
1.39% |
|
|
|
|
|
N/A |
0.00% |
27.07% |
22.47% |
|---|
| BMY |
Bristol-Myers Squibb Company |
0 |
1.36% |
|
|
|
|
|
N/A |
0.00% |
31.00% |
27.64% |
|---|
| FOLD |
Amicus Therapeutics, Inc. |
0 |
1.35% |
|
|
|
|
|
N/A |
0.00% |
51.71% |
46.71% |
|---|
| NOVN.SW |
Novartis AG |
|
1.33% |
|
|
|
|
|
|
|
|
|
|---|
| LH |
Laboratory Corporation of America Holdin... |
0 |
1.29% |
|
|
|
|
|
N/A |
0.00% |
25.73% |
19.23% |
|---|
| AMGN |
Amgen Inc. |
0 |
1.29% |
|
|
|
|
|
N/A |
0.00% |
34.50% |
47.20% |
|---|
| QGEN |
Qiagen N.V. |
0 |
1.28% |
|
|
|
|
|
N/A |
0.00% |
48.39% |
22.72% |
|---|
| TSN |
Tyson Foods, Inc. |
0 |
1.27% |
|
|
|
|
|
N/A |
0.00% |
30.68% |
8.99% |
|---|
| CTVA |
Corteva, Inc. |
0 |
1.24% |
|
|
|
|
|
N/A |
0.00% |
34.83% |
12.98% |
|---|
| BNTX |
BioNTech SE |
0 |
1.24% |
|
|
|
|
|
N/A |
0.00% |
45.15% |
32.29% |
|---|
| ZTS |
Zoetis Inc. |
0 |
1.21% |
|
|
|
|
|
N/A |
0.00% |
29.70% |
24.44% |
|---|
| TMO |
Thermo Fisher Scientific Inc. |
0 |
1.20% |
|
|
|
|
|
N/A |
0.00% |
33.54% |
33.14% |
|---|
| IONS |
Ionis Pharmaceuticals, Inc. |
0 |
1.19% |
|
|
|
|
|
N/A |
0.00% |
57.02% |
22.76% |
|---|
| STOK |
Stoke Therapeutics, Inc. |
0 |
1.18% |
|
|
|
|
|
N/A |
0.00% |
405.70% |
34.50% |
|---|
| JNJ |
Johnson & Johnson |
0 |
1.17% |
|
|
|
|
|
N/A |
0.00% |
19.10% |
20.87% |
|---|
| RGEN |
Repligen Corporation |
0 |
1.16% |
|
|
|
|
|
N/A |
0.00% |
50.01% |
19.22% |
|---|
| SYENS BB |
Syensqo Sa |
|
1.16% |
|
|
|
|
|
|
|
|
|
|---|
| REGN |
Regeneron Pharmaceuticals, Inc. |
0 |
1.14% |
|
|
|
|
|
N/A |
0.00% |
40.67% |
53.12% |
|---|
| AZN |
AstraZeneca PLC |
0 |
1.12% |
|
|
|
|
|
N/A |
0.00% |
23.46% |
22.30% |
|---|
| MRK |
Merck & Co., Inc. |
0 |
1.12% |
|
|
|
|
|
N/A |
0.00% |
36.29% |
48.54% |
|---|
| EXAS |
Exact Sciences Corporation |
0 |
1.12% |
|
|
|
|
|
N/A |
0.00% |
46.55% |
11.01% |
|---|
| TECH |
Bio-Techne Corporation |
0 |
1.10% |
|
|
|
|
|
N/A |
0.00% |
40.49% |
52.71% |
|---|
| ILMN |
Illumina, Inc. |
0 |
1.10% |
|
|
|
|
|
N/A |
0.00% |
41.31% |
22.70% |
|---|
| DAR |
Darling Ingredients Inc. |
0 |
1.08% |
|
|
|
|
|
N/A |
0.00% |
42.97% |
24.91% |
|---|
| CRSP |
CRISPR Therapeutics AG |
0 |
1.07% |
|
|
|
|
|
N/A |
0.00% |
54.77% |
39.68% |
|---|
| ARCT |
Arcturus Therapeutics Holdings Inc. |
0 |
1.00% |
|
|
|
|
|
N/A |
0.00% |
84.60% |
49.32% |
|---|
| BIO |
Bio-Rad Laboratories, Inc. |
0 |
0.98% |
|
|
|
|
|
N/A |
0.00% |
48.05% |
27.62% |
|---|
| MYGN |
Myriad Genetics, Inc. |
0 |
0.96% |
|
|
|
|
|
N/A |
0.00% |
60.35% |
59.06% |
|---|
| DOW |
Dow Inc. |
0 |
0.96% |
|
|
|
|
|
N/A |
0.00% |
43.12% |
37.70% |
|---|
| 4502.T |
Takeda Pharmaceutical Co Ltd |
|
0.94% |
|
|
|
|
|
|
|
|
|
|---|
| ARGX |
argenx SE |
0 |
0.92% |
|
|
|
|
|
N/A |
0.00% |
31.77% |
27.68% |
|---|
| GMAB |
Genmab A/S |
0 |
0.91% |
|
|
|
|
|
N/A |
0.00% |
74.56% |
47.75% |
|---|
| ARWR |
Arrowhead Pharmaceuticals, Inc. |
0 |
0.90% |
|
|
|
|
|
N/A |
0.00% |
56.04% |
28.59% |
|---|
| PFE |
Pfizer Inc. |
0 |
0.86% |
|
|
|
|
|
N/A |
0.00% |
26.97% |
13.94% |
|---|
| FATE |
Fate Therapeutics, Inc. |
0 |
0.83% |
|
|
|
|
|
N/A |
0.00% |
236.51% |
32.17% |
|---|
| ADM |
Archer-Daniels-Midland Company |
0 |
0.83% |
|
|
|
|
|
N/A |
0.00% |
26.19% |
19.95% |
|---|
| SDGR |
Schrödinger, Inc. |
0 |
0.82% |
|
|
|
|
|
N/A |
0.00% |
64.27% |
46.02% |
|---|
| BMRN |
BioMarin Pharmaceutical Inc. |
0 |
0.80% |
|
|
|
|
|
N/A |
0.00% |
33.04% |
35.06% |
|---|
| NTR |
Nutrien Ltd. |
0 |
0.80% |
|
|
|
|
|
N/A |
0.00% |
24.95% |
5.45% |
|---|
| ACLX |
Arcellx, Inc. |
0 |
0.72% |
|
|
|
|
|
N/A |
0.00% |
46.12% |
38.93% |
|---|
| BAYN.DE |
Bayer AG |
|
0.69% |
|
|
|
|
|
|
|
|
|
|---|
| RVMD |
Revolution Medicines, Inc. |
0 |
0.68% |
|
|
|
|
|
N/A |
0.00% |
66.81% |
45.98% |
|---|
| BHVN |
Biohaven Pharmaceutical Holding Company ... |
0 |
0.68% |
|
|
|
|
|
N/A |
0.00% |
62.50% |
58.75% |
|---|
| FMC |
FMC Corporation |
0 |
0.67% |
|
|
|
|
|
N/A |
0.00% |
46.58% |
17.46% |
|---|
| BIIB |
Biogen Inc. |
0 |
0.64% |
|
|
|
|
|
N/A |
0.00% |
37.26% |
39.84% |
|---|
| LNZ AV |
Lenzing AG |
|
0.64% |
|
|
|
|
|
|
|
|
|
|---|
| NUF.AX |
Nufarm Ltd/Australia |
|
0.59% |
|
|
|
|
|
|
|
|
|
|---|
| TEM |
Tempus Ai Inc |
|
0.58% |
|
|
|
|
|
|
|
|
|
|---|
| VERV |
Verve Therapeutics, Inc. |
0 |
0.58% |
|
|
|
|
|
N/A |
0.00% |
154.23% |
18.14% |
|---|
| DNA |
Ginkgo Bioworks Holdings, Inc. |
0 |
0.57% |
|
|
|
|
|
N/A |
0.00% |
116.17% |
6.56% |
|---|
| GPCR |
Structure Therapeutics Inc. |
0 |
0.56% |
|
|
|
|
|
N/A |
0.00% |
82.10% |
49.69% |
|---|
| PACB |
Pacific Biosciences of California, Inc. |
0 |
0.55% |
|
|
|
|
|
N/A |
0.00% |
120.73% |
46.31% |
|---|
| RGNX |
REGENXBIO Inc. |
0 |
0.54% |
|
|
|
|
|
N/A |
0.00% |
652.49% |
29.91% |
|---|
| ALLO |
Allogene Therapeutics, Inc. |
0 |
0.53% |
|
|
|
|
|
N/A |
0.00% |
677.77% |
54.86% |
|---|
| ONT.L |
Oxford Nanopore Technologies |
|
0.49% |
|
|
|
|
|
|
|
|
|
|---|
| GNS.L |
Genus Plc |
|
0.49% |
|
|
|
|
|
|
|
|
|
|---|
| CRBU |
Caribou Biosciences, Inc. |
0 |
0.47% |
|
|
|
|
|
N/A |
0.00% |
1,000.13% |
21.32% |
|---|
| CVAC |
CureVac N.V. |
0 |
0.45% |
|
|
|
|
|
N/A |
0.00% |
155.24% |
25.68% |
|---|
| TXG |
10x Genomics, Inc. |
0 |
0.45% |
|
|
|
|
|
N/A |
0.00% |
81.27% |
35.40% |
|---|
| GPRE |
Green Plains Inc. |
0 |
0.43% |
|
|
|
|
|
N/A |
0.00% |
77.89% |
45.44% |
|---|
| NTLA |
Intellia Therapeutics, Inc. |
0 |
0.42% |
|
|
|
|
|
N/A |
0.00% |
84.48% |
58.18% |
|---|
| 4974.T |
Takara Bio Inc |
|
0.41% |
|
|
|
|
|
|
|
|
|
|---|
| BYND |
Beyond Meat, Inc. |
0 |
0.38% |
|
|
|
|
|
N/A |
0.00% |
467.32% |
4.60% |
|---|
| ORGN |
Origin Materials, Inc. |
0 |
0.37% |
|
|
|
|
|
N/A |
0.00% |
121.69% |
23.38% |
|---|
| MRNA |
Moderna, Inc. |
0 |
0.35% |
|
|
|
|
|
N/A |
0.00% |
67.24% |
33.78% |
|---|
| SOLB BB |
Solvay SA |
|
0.35% |
|
|
|
|
|
|
|
|
|
|---|
| ABSI |
Absci Corporation |
0 |
0.34% |
|
|
|
|
|
N/A |
0.00% |
150.79% |
41.74% |
|---|
| VBK.DE |
Verbio AG |
|
0.27% |
|
|
|
|
|
|
|
|
|
|---|
| EDIT |
Editas Medicine, Inc. |
0 |
0.25% |
|
|
|
|
|
N/A |
0.00% |
146.68% |
34.80% |
|---|
| SANA |
Sana Biotechnology, Inc. |
0 |
0.23% |
|
|
|
|
|
N/A |
0.00% |
214.00% |
21.37% |
|---|